Ophthalmic Surgery, Lasers and Imaging Retina

Clinical Science 

Research Developments in the Treatment of Retinal Disease: Finalists From the Inaugural Retina Research Scholar Honoree Program

Rishi P. Singh, MD

Abstract

Ophthalmology residents and fellows are in a unique position within the medical setting with access to textbooks and solid evidenced-based materials. However, when these trainees are exposed to clinical environments, they soon realize that some medical decisions in care are not always supported by studies or data. As inquisitive scholars, they can ask questions and seek answers. What does this imaging finding mean for the patient? Does this clinical feature portend a better prognosis? What intervention should I perform to maximize the visual outcome?

These are some of the many questions asked in the 2017 Retina Research Scholar Honoree Program. The goal of this program is to celebrate their research accomplishments, expose them to their peers who are also contributing to the field, and to award those for truly exceptional research. Of the many presentations received, only a select few made it to the oral presentation symposium held just before the American Academy of Ophthalmology 2017 Annual Meeting in New Orleans. In this supplement, we highlight five of these presentations.

This program would not be possible without support from educational grants from Regeneron Pharmaceuticals and Carl Zeiss Meditec, Inc. On behalf of the judging committee for the Retina Research Scholar Honoree Program, I would also like to thank Ophthalmology Times for its involvement with this research program and would like to congratulate all participants. We look forward to the presentations in 2018.

Rishi P. Singh, MD
Cole Eye Institute
Cleveland Clinic Foundation
Associate Editor, OSLI Retina…

Ophthalmology residents and fellows are in a unique position within the medical setting with access to textbooks and solid evidenced-based materials. However, when these trainees are exposed to clinical environments, they soon realize that some medical decisions in care are not always supported by studies or data. As inquisitive scholars, they can ask questions and seek answers. What does this imaging finding mean for the patient? Does this clinical feature portend a better prognosis? What intervention should I perform to maximize the visual outcome?

These are some of the many questions asked in the 2017 Retina Research Scholar Honoree Program. The goal of this program is to celebrate their research accomplishments, expose them to their peers who are also contributing to the field, and to award those for truly exceptional research. Of the many presentations received, only a select few made it to the oral presentation symposium held just before the American Academy of Ophthalmology 2017 Annual Meeting in New Orleans. In this supplement, we highlight five of these presentations.

This program would not be possible without support from educational grants from Regeneron Pharmaceuticals and Carl Zeiss Meditec, Inc. On behalf of the judging committee for the Retina Research Scholar Honoree Program, I would also like to thank Ophthalmology Times for its involvement with this research program and would like to congratulate all participants. We look forward to the presentations in 2018.

Rishi P. Singh, MD

Cole Eye Institute

Cleveland Clinic Foundation

Associate Editor, OSLI Retina

Authors

10.3928/23258160-20180814-01

Sign up to receive

Journal E-contents